GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Intrinsic Value: Projected FCF

Molekule Group (Molekule Group) Intrinsic Value: Projected FCF : $0.00 (As of May. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-13), Molekule Group's Intrinsic Value: Projected FCF is $0.00. The stock price of Molekule Group is $0.0004. Therefore, Molekule Group's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Molekule Group's Intrinsic Value: Projected FCF or its related term are showing as below:

MKULQ's Price-to-Projected-FCF is not ranked *
in the Industrial Products industry.
Industry Median: 1.56
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Molekule Group Intrinsic Value: Projected FCF Historical Data

The historical data trend for Molekule Group's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Intrinsic Value: Projected FCF Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Intrinsic Value: Projected FCF
- - - -

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Molekule Group's Intrinsic Value: Projected FCF

For the Pollution & Treatment Controls subindustry, Molekule Group's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molekule Group's Price-to-Projected-FCF Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Molekule Group's Price-to-Projected-FCF falls into.



Molekule Group Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Molekule Group  (OTCPK:MKULQ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Molekule Group's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0004/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Molekule Group's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (Molekule Group) Business Description

Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410